Home Compare LITE vs MRNA
Stock Comparison · Single-driver result

Lumentum Holdings vs Moderna: Which Stock Looks Stronger in 2026?

Lumentum holds the cleaner structural position, with the lead spread across growth and stability. Moderna still leads on profitability and valuation, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Most of the separation is still concentrated in growth. Lumentum Holdings Inc. leads by 10 points on the overall comparison score.

Trajectory Similarity
0.67
Moderately similar
Peer-set rank: #5
within Lumentum Holdings Inc.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The clearest structural overlap shows up in revenue stability.

Similarity drivers
revenue stability
What reduces the match
margin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
LITE
Lumentum Holdings Inc.
26
Peer-Score
Signal qualityMedium
vs
MRNA
Moderna, Inc.
16
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: LITE vs MRNA Profitability 2 15 Stability 31 3 Valuation 9 30 Growth 85 9 LITE MRNA
Gap Ranking
#1 Growth +76
#2 Stability +28
#3 Valuation +21
#4 Profitability +13
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for LITE and MRNA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer LITEMRNA Relative valuation Structural strength

Lumentum Holdings Inc. looks stronger, but the price setup still looks more supportive for Moderna, Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) and peer-relative valuation score where available.

Relative Position vs Comparable Companies
Growth
Lumentum Holdings Inc. ranks near the top of the group on growth; Moderna, Inc. sits in the weaker half.
Stability
Neither side looks especially strong on stability, though Lumentum Holdings Inc. still ranks somewhat higher.
Growth — Dominant Gap
LITE
85
MRNA
9
Gap+76in favour of LITE

One company is still expanding while the other is contracting, which creates a very wide growth split.

What else supports the lead

Stability also supports the lead, so the result is broader than one isolated gap.

What this means for the comparison

The lead is built on both growth and stability — though profitability still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the LITE vs MRNA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how LITE and MRNA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.